JPWO2022202566A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022202566A5
JPWO2022202566A5 JP2022565919A JP2022565919A JPWO2022202566A5 JP WO2022202566 A5 JPWO2022202566 A5 JP WO2022202566A5 JP 2022565919 A JP2022565919 A JP 2022565919A JP 2022565919 A JP2022565919 A JP 2022565919A JP WO2022202566 A5 JPWO2022202566 A5 JP WO2022202566A5
Authority
JP
Japan
Prior art keywords
decanoic acid
increasing
acid
free
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022565919A
Other languages
English (en)
Japanese (ja)
Other versions
JP7245399B2 (ja
JPWO2022202566A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/012042 external-priority patent/WO2022202566A1/ja
Publication of JPWO2022202566A1 publication Critical patent/JPWO2022202566A1/ja
Publication of JPWO2022202566A5 publication Critical patent/JPWO2022202566A5/ja
Priority to JP2023037718A priority Critical patent/JP7520175B2/ja
Application granted granted Critical
Publication of JP7245399B2 publication Critical patent/JP7245399B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022565919A 2021-03-26 2022-03-16 血中デカン酸濃度の上昇方法、血中デカン酸濃度上昇剤、医薬組成物、食品組成物 Active JP7245399B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023037718A JP7520175B2 (ja) 2021-03-26 2023-03-10 血中デカン酸濃度の上昇方法、血中デカン酸濃度上昇剤、医薬組成物、食品組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021053119 2021-03-26
JP2021053119 2021-03-26
PCT/JP2022/012042 WO2022202566A1 (ja) 2021-03-26 2022-03-16 血中デカン酸濃度の上昇方法、血中デカン酸濃度上昇剤、医薬組成物、食品組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023037718A Division JP7520175B2 (ja) 2021-03-26 2023-03-10 血中デカン酸濃度の上昇方法、血中デカン酸濃度上昇剤、医薬組成物、食品組成物

Publications (3)

Publication Number Publication Date
JPWO2022202566A1 JPWO2022202566A1 (https=) 2022-09-29
JPWO2022202566A5 true JPWO2022202566A5 (https=) 2023-02-21
JP7245399B2 JP7245399B2 (ja) 2023-03-23

Family

ID=83397132

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022565919A Active JP7245399B2 (ja) 2021-03-26 2022-03-16 血中デカン酸濃度の上昇方法、血中デカン酸濃度上昇剤、医薬組成物、食品組成物
JP2023037718A Active JP7520175B2 (ja) 2021-03-26 2023-03-10 血中デカン酸濃度の上昇方法、血中デカン酸濃度上昇剤、医薬組成物、食品組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023037718A Active JP7520175B2 (ja) 2021-03-26 2023-03-10 血中デカン酸濃度の上昇方法、血中デカン酸濃度上昇剤、医薬組成物、食品組成物

Country Status (5)

Country Link
US (1) US20240156773A1 (https=)
EP (1) EP4316484A4 (https=)
JP (2) JP7245399B2 (https=)
CN (1) CN116981454A (https=)
WO (1) WO2022202566A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4316484A4 (en) * 2021-03-26 2024-12-18 The Nisshin Oillio Group, Ltd. Method for raising blood decanoic acid concentration, blood-decanoic-acid-concentration-raising agent, pharmaceutical composition, and food composition
JP7851286B2 (ja) * 2023-11-24 2026-04-24 太陽油脂株式会社 糖代謝異常改善用油脂及び腸内環境改善用油脂

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871768A (en) * 1984-07-12 1989-10-03 New England Deaconess Hospital Corporation Dietary supplement utilizing ω-3/medium chain trigylceride mixtures
US5851510A (en) * 1994-05-16 1998-12-22 The Board Of Regents Of The University Of Michigan Hepatocyte-selective oil-in-water emulsion
DE10130491A1 (de) * 2001-06-25 2003-04-17 Heirler Horst Verwendung von mittelkettigen Triglyceriden zur Prävention und Therapie von Adipositas
EP1479666A4 (en) 2002-02-28 2010-10-13 Japan Tobacco Inc ESTER CONNECTION AND THEIR MEDICAL USE
WO2004022049A1 (ja) * 2002-09-05 2004-03-18 The Nisshin Oillio Group, Ltd. 痩身剤およびその飲食物
CN102791264B (zh) * 2010-03-31 2014-09-03 日清奥利友集团株式会社 用于预防或治疗糖尿病的油脂组合物
CN107205419B (zh) * 2015-01-26 2021-12-07 日清奥利友集团株式会社 油脂
JP2018052818A (ja) 2015-01-28 2018-04-05 武田薬品工業株式会社 スルホンアミド化合物
US11738087B2 (en) * 2015-09-08 2023-08-29 Monash University Lymph directing prodrugs
EP4316484A4 (en) * 2021-03-26 2024-12-18 The Nisshin Oillio Group, Ltd. Method for raising blood decanoic acid concentration, blood-decanoic-acid-concentration-raising agent, pharmaceutical composition, and food composition

Similar Documents

Publication Publication Date Title
US20220347147A1 (en) Compositions comprising 15-ohepa and methods of using the same
JPWO2022202566A5 (https=)
WO2009091538A8 (en) Pharmaceutical composition comprising epa and dha for treating hypertriglyceridemia and hypercholesterolemia
WO2017139846A1 (en) Formulation and method of use
WO2019106851A1 (ja) 非アルコール性脂肪性肝疾患(naflad)および/または非アルコール性脂肪性肝炎(nash)、および/または肝脂肪性変性の治療と予防に適した、配合剤
JP7721084B2 (ja) アポトーシスを治療しプログラム細胞死を変更する方法
CN101426492A (zh) 饮食后血中胰岛素上升抑制剂
CA2551119C (en) Lipase inhibitor
JP7236119B2 (ja) 大動脈瘤の予防用医薬組成物および加工食品
JPWO2022138826A5 (https=)
JP4707839B2 (ja) 糖尿病予防治療剤
JPH04244023A (ja) ω6系不飽和脂肪酸含有薬剤
JP2023527454A5 (https=)
JP5759663B2 (ja) 皮膚バリア機能改善剤等
RU2018147077A (ru) Комбинация метаболических биоэнергетических и нутра-эпигенетических регуляторов, нутрицевтических соединений в традиционных и нанотехнологических комбинациях для возвращения в прежнее состояние и предотвращения хронического повреждения, ускоренного клеточной чувствительностью, вызванной сахарным диабетом и другими дегенеративными хроническими комплексными заболеваниями
Baay The Role of Omega-3 EPA/DHA Oral Soft gel in The Treatment of Stable Bronchiectasis
JP2024065091A (ja) 傷害および/または皮膚症状を処置するための組成物および方法
WO2022124390A1 (ja) 大動脈瘤の予防および治療用医薬組成物および加工食品
JP2005225863A (ja) リパーゼ阻害剤
JP2016513647A5 (https=)
Simon Dietary management of inflammatory bowel disease
JP2009013179A (ja) インスリン抵抗性改善剤
HK1200351B (en) Compositions comprising 15-hepe and methods of using the same
JP2013203693A (ja) ギンコライドと魚介油を含有する組成物